Tylenol in pregnancy: A question of safety or control?

Taking stock of the drug industry, from the lab to the medicine chest

September 16, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe Opinion: Tylenol in pregnancy: a question of safety or control? Pregnant people with headaches, nausea, or depression are too often told that their suffering is always worth it. By Christine Henneberg STAT+ | Critics call on Sarepta to show how it's measuring gene therapy's performance Experts in the know say Sarepta's Elevidys Duchenne therapy may overstate how much gene it delivers — raising new questions about its true benefit. By Jason Mast STAT+ | Surgeon general nominee Casey Means discloses financial ties to supplement industry Surgeon general nominee discloses earning hundreds of thousands of dollars promoting supplements, vows to divest her husband's investments in tobacco companies. By Sarah Todd and Isabella Cueto Adobe Opinion: I'm a former CDC director. I'm deeply concerned about the future of vaccines in the U.S. Former CDC Director Rochelle Walensky writes that politicians are using real and perceived Covid shortcomings to limit vaccine access By Rochelle Walensky

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser